Table 1.
Univariate Cox Analysis | Multivariate Cox Analysis 1 | |||||
---|---|---|---|---|---|---|
Gene 2 | HR | 95% CI | p-Value | HR | 95% CI | p-Value |
Poor OS | ||||||
LINC01089 | 1.002 | 1–1.003 | 0.0479 * | 1.002 | 0.9997–1.003 | 0.101 |
RGS11 | 1 | 1–1.001 | 0.0291 * | 1 | 1–1.001 | 0.0697 |
MXD3 | 1.003 | 1.002–1.004 | 8.53 × 10−7 *** | 1.003 | 1.0016–1.004 | 2.75 × 10−5 *** |
BIRC5 | 1.003 | 1.002–1.004 | 1.45 × 10−9 *** | 1.002 | 1.0014–1.003 | 8.79 × 10−7 *** |
RAB30 | 1.008 | 1.003–1.013 | 0.00283 ** | 1.006 | 1.001–1.012 | 0.0122* |
worse PFS | ||||||
LCN12 | 1.007 | 1.001–1.013 | 0.0187 * | 1.011 | 1.0004–1.018 | 0.00172 ** |
VGF | 1 | 1–1 | 0.00124 ** | 1 | 1–1 | 0.0463 * |
RGS11 | 1.001 | 1–1.001 | 0.00271 ** | 1.001 | 1.0001–1.001 | 0.0207 * |
MXD3 | 1.002 | 1.001–1.003 | 0.000676 *** | 1.0017 | 1.0005–1.003 | 0.00495 ** |
BIRC5 | 1.002 | 1.001–1.002 | 6.13 × 10−5 *** | 1.001 | 1.0002–1.002 | 0.0196 * |
RAB30 | 1.02 | 1.005–1.014 | 1.92 × 10−5 *** | 1.0099 | 1.0053–1.014 | 1.94 × 10−5 *** |
NOD2 | 1.007 | 1.001–1.014 | 0.0237 * | 1.0064 | 1.0003–1.012 | 0.0394 * |
ZFHX4 | 1 | 1–1.001 | 0.035 * | 1.001 | 1.0001–1.001 | 0.0235 * |
1: In analysis with age at diagnosis and tumor stage (stage 1 (3 + 4) vs. stage 0 (1 + 2)); 2: continuous gene expression data were used in analysis; * p < 0.05; ** p < 0.01; *** p < 0.001.